CN117651553A - 用于治疗萎缩性瘢痕的犬尿氨酸及其衍生物 - Google Patents
用于治疗萎缩性瘢痕的犬尿氨酸及其衍生物 Download PDFInfo
- Publication number
- CN117651553A CN117651553A CN202280033219.4A CN202280033219A CN117651553A CN 117651553 A CN117651553 A CN 117651553A CN 202280033219 A CN202280033219 A CN 202280033219A CN 117651553 A CN117651553 A CN 117651553A
- Authority
- CN
- China
- Prior art keywords
- kynurenine
- hydroxy
- scars
- atrophic
- acne
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/267—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Birds (AREA)
- Inorganic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Luminescent Compositions (AREA)
- Apparatus For Radiation Diagnosis (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163185994P | 2021-05-07 | 2021-05-07 | |
| US63/185,994 | 2021-05-07 | ||
| PCT/CA2022/050722 WO2022232950A1 (en) | 2021-05-07 | 2022-05-09 | Kynrenine and derivatives thereof for treating atrophic scarring |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN117651553A true CN117651553A (zh) | 2024-03-05 |
Family
ID=83932596
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202280033219.4A Pending CN117651553A (zh) | 2021-05-07 | 2022-05-09 | 用于治疗萎缩性瘢痕的犬尿氨酸及其衍生物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240226085A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4322936A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024516316A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240004954A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117651553A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022269054A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023023213A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3216907A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023013100A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022232950A1 (cg-RX-API-DMAC7.html) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119950473A (zh) * | 2025-03-04 | 2025-05-09 | 中国海洋大学 | L-犬尿氨酸在制备预防和/或治疗紫外光诱导的皮肤光损伤的药物中的应用 |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1038516A1 (en) * | 1999-03-16 | 2000-09-27 | Saburoh Uchikuga | Cosmetic composition comprising kynurenine |
| JP2002053448A (ja) * | 2000-07-28 | 2002-02-19 | Pentapharm Ltd | アウトドア化粧料 |
| WO2009046874A1 (en) * | 2007-09-11 | 2009-04-16 | Mondobiotech Laboratories Ag | Therapeutic combination of trh-potentiating peptide and stresscopin |
| US20100197605A1 (en) * | 2007-09-11 | 2010-08-05 | Dorian Bevec | Therapeutic use of peptide yglf and combination with kvlpvpq |
| US20160120857A1 (en) * | 2013-06-05 | 2016-05-05 | The University Of British Columbia | Anti-Fibrogenic Compounds, Methods and Uses Thereof |
| US20160228453A1 (en) * | 2013-09-26 | 2016-08-11 | Galderma S.A. | Prostaglandin F2Alpha and Analogues Thereof for Treating Atrophic Cutaneous Scarring |
| WO2018136884A1 (en) * | 2017-01-23 | 2018-07-26 | The Regents Of The University Of California | Compositions and methods for treating obesity and inducing weight loss |
| US20210052535A1 (en) * | 2018-05-23 | 2021-02-25 | Epitracker, Inc. | Compositions and methods for diagnosis and treatment of conditions related to the quality of aging and longevity |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01102018A (ja) * | 1987-10-16 | 1989-04-19 | Sogo Yatsukou Kk | 化粧料 |
| FR3042710B1 (fr) * | 2015-10-22 | 2019-12-13 | Jean-Noel Thorel | Composition a base de dihydromyricetine et d'un sel de zinc pour le traitement de l'acne et des peaux grasses |
-
2022
- 2022-05-09 KR KR1020237041823A patent/KR20240004954A/ko active Pending
- 2022-05-09 EP EP22798489.5A patent/EP4322936A4/en active Pending
- 2022-05-09 CA CA3216907A patent/CA3216907A1/en active Pending
- 2022-05-09 AU AU2022269054A patent/AU2022269054A1/en active Pending
- 2022-05-09 JP JP2023568440A patent/JP2024516316A/ja active Pending
- 2022-05-09 BR BR112023023213A patent/BR112023023213A2/pt unknown
- 2022-05-09 MX MX2023013100A patent/MX2023013100A/es unknown
- 2022-05-09 WO PCT/CA2022/050722 patent/WO2022232950A1/en not_active Ceased
- 2022-05-09 CN CN202280033219.4A patent/CN117651553A/zh active Pending
- 2022-05-09 US US18/559,181 patent/US20240226085A1/en active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1038516A1 (en) * | 1999-03-16 | 2000-09-27 | Saburoh Uchikuga | Cosmetic composition comprising kynurenine |
| JP2002053448A (ja) * | 2000-07-28 | 2002-02-19 | Pentapharm Ltd | アウトドア化粧料 |
| WO2009046874A1 (en) * | 2007-09-11 | 2009-04-16 | Mondobiotech Laboratories Ag | Therapeutic combination of trh-potentiating peptide and stresscopin |
| US20100197605A1 (en) * | 2007-09-11 | 2010-08-05 | Dorian Bevec | Therapeutic use of peptide yglf and combination with kvlpvpq |
| US20160120857A1 (en) * | 2013-06-05 | 2016-05-05 | The University Of British Columbia | Anti-Fibrogenic Compounds, Methods and Uses Thereof |
| US20160228453A1 (en) * | 2013-09-26 | 2016-08-11 | Galderma S.A. | Prostaglandin F2Alpha and Analogues Thereof for Treating Atrophic Cutaneous Scarring |
| WO2018136884A1 (en) * | 2017-01-23 | 2018-07-26 | The Regents Of The University Of California | Compositions and methods for treating obesity and inducing weight loss |
| US20210052535A1 (en) * | 2018-05-23 | 2021-02-25 | Epitracker, Inc. | Compositions and methods for diagnosis and treatment of conditions related to the quality of aging and longevity |
Non-Patent Citations (2)
| Title |
|---|
| MALIHE-SADAT POORMASJEDI-MEIBOD,ET AL: "Anti-Scarring Properties of Different Tryptophan Derivatives", PLOS ONE, vol. 09, no. 03, 17 March 2014 (2014-03-17), pages 1 * |
| SZELEST M , ET AL: ".A New Insight into the Potential Role of Tryptophan-Derived AhR Ligands in Skin Physiological and Pathological Processes", INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol. 22, no. 03, 22 January 2021 (2021-01-22), pages 1104 - 1135 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119950473A (zh) * | 2025-03-04 | 2025-05-09 | 中国海洋大学 | L-犬尿氨酸在制备预防和/或治疗紫外光诱导的皮肤光损伤的药物中的应用 |
| CN119950473B (zh) * | 2025-03-04 | 2026-01-27 | 中国海洋大学 | L-犬尿氨酸在制备预防和/或治疗紫外光诱导的皮肤光损伤的药物中的应用 |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20240004954A (ko) | 2024-01-11 |
| JP2024516316A (ja) | 2024-04-12 |
| EP4322936A4 (en) | 2025-03-19 |
| EP4322936A1 (en) | 2024-02-21 |
| AU2022269054A1 (en) | 2023-11-23 |
| CA3216907A1 (en) | 2022-11-10 |
| US20240226085A1 (en) | 2024-07-11 |
| WO2022232950A1 (en) | 2022-11-10 |
| BR112023023213A2 (pt) | 2024-01-30 |
| MX2023013100A (es) | 2024-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6966455B2 (ja) | 侵襲的且つ非侵襲的な処置上のスキンケアのための組成物及び方法 | |
| JP2020529980A (ja) | 皮膚の弛緩と身体の輪郭を改善するための組成物および方法 | |
| US20110009374A1 (en) | Method of wound healing and scar modulation | |
| EP2691077B1 (en) | Salicylic acid topical formulation | |
| WO2008037262A1 (en) | Wound healing composition comprising phosphate, iron and copper | |
| EP2563357B1 (en) | Adapalene 0.3% for use in a method for treating scars | |
| JP2021535925A (ja) | プラスミノーゲンアクチベーターインヒビター1(plasminogen activator inhibitor 1)(PAI−1)阻害剤(inhibitor)およびその使用 | |
| WO2015179570A1 (en) | Waterborne topical compositions for the delivery of azelaic acid for treatment of skin conditions such as acne vulgaris, rosacea seborrheic dermatitis | |
| JP2025529453A (ja) | 皺皮および皺の外観を軽減するために低分子の化学化合物を使用する方法 | |
| JP5553284B2 (ja) | 皮膚の老化や瘢痕の治療剤 | |
| US20240226085A1 (en) | Kynrenine and derivatives thereof for treating atrophic scarring | |
| JP6453318B2 (ja) | 委縮性皮膚瘢痕を治療するためのプロスタグランジンF2α及びその類似体 | |
| US20250073251A1 (en) | Compositions and methods and uses thereof | |
| HK40102967A (en) | Kynurenine and derivatives thereof for treating atrophic scarring | |
| JP7361448B2 (ja) | トランスグルタミナーゼ発現促進剤 | |
| US20250255792A1 (en) | Methods of Using a Small Molecule Chemical Compound to Reduce the Appearance of Rhytids and Wrinkles | |
| KR102540969B1 (ko) | 소듐 2-메르캅토에탄 설포네이트를 함유하는 피부 재생 촉진용 조성물 | |
| JP2017088559A (ja) | フィラグリン産生促進剤 | |
| EP4382104A1 (en) | Dyclonine for use in the topical treatment of hand-foot syndrome | |
| HK40118960A (en) | Methods of using a small molecule chemical compound to reduce the appearance of rhytids and wrinkles | |
| KR102336699B1 (ko) | 소듐 2-메르캅토에탄 설포네이트를 함유하는 히알루론산의 분해억제제 및 이를 포함하는 조성물 | |
| EP4262748A1 (en) | A mucosal re-epithelialization composition | |
| MX2013001099A (es) | Crema o gel de aplicación tópica con neurotoxina botulinica encapsulada en nanoparticulas liposomales para el tratamiento de la hiperhidrosis. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40102967 Country of ref document: HK |